Key details
Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Enrollment target
~472 participants
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated December 2024